1Lipponen PK,Eskelinen MJ,Jakhiainen K,et al.Tumor infiltrating lymphocytes as an independent prognostic fact or in transitional cell bladder cancer.Eur J Cancer,1991,29(1):69-75.
2Kruger K,Buning C,Schriever F.Activated T lymphocytes bind in situ to stromal tissue of colon carcinoma but lack adhesion to tumor cells.Eur J Immunol,2001,31:138-145.
3Michel F, Attal Bonnefoy G, Mangino G, et al. CD28 as a molecular amplifier extending TCR ligation and signaling capabilities [ J ]. Immunity, 2001,15 (9) : 935 -945.
4Alves NL, Arosa FA, Van Lier RA. IL-21 sustains CD28 expression on IL-15-activated human naive CD8^+ T cells[J]. J Immunol, 2005,175 (2) :755- 762.
5Godlove J, Chiu WK, Weng NP. Gene expression and generation of CD28 - CD8 T cells mediated by interleu- kin 15[J]. Exp Gerontol, 2007, 42(5) :412-415.
6Martinez Escribano JA, Hernadez Caselles T, Campillo JA, et al. Changes in the number of CD80^+, CD86 ^+ and CD28 ^+ peripheral blood lymphocytes have prognostic value in melanoma patients [ J ]. Hum Immunol, 2003, 64(8):796-780.
7Tsukishiro T, Donnenbrerg AD, Whiteside TL. Rapid turnover of the CD8( + ) CD28( - ) T-cell subset of effector cells in the circulation of patients with head and meck cancer[J]. Cancer Immunol Innunother, 2003, 52(10) :599-607.
